Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics
Authors
Keywords
-
Journal
MOLECULES
Volume 21, Issue 3, Pages 337
Publisher
MDPI AG
Online
2016-03-10
DOI
10.3390/molecules21030337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitropotential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs
- (2016) Qing Miao et al. PHARMACEUTICAL BIOLOGY
- Effects of Baicalin on Oral Pharmacokinetics of Caffeine in Rats
- (2015) Keumhan Noh et al. Biomolecules & Therapeutics
- Multiple ABC Transporters Efflux Baicalin
- (2015) Bernadett Kalapos-Kovács et al. PHYTOTHERAPY RESEARCH
- Comparative pharmacokinetics of a marker compound, baicalin in KOB extract after oral administration to normal and allergic-induced rats
- (2014) Jong-Suep Baek et al. DRUG DELIVERY
- Comparative metabolism of Radix scutellariae extract by intestinal bacteria from normal and type 2 diabetic mice in vitro
- (2014) Jun Xu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- (2014) Thomas P Van Boeckel et al. LANCET INFECTIOUS DISEASES
- Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein
- (2014) Young-Ah Cho et al. Pharmacological Reports
- Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats
- (2014) Na Gao et al. PLoS One
- Contribution of Baicalin on the Plasma Protein Binding Displacement and CYP3A Activity Inhibition to the Pharmacokinetic Changes of Nifedipine in Rats In Vivo and In Vitro
- (2014) Zhen-Yu Cheng et al. PLoS One
- Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin
- (2013) Mi Jeong Kang et al. ARCHIVES OF PHARMACAL RESEARCH
- Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats
- (2013) Xin Tian et al. Evidence-based Complementary and Alternative Medicine
- The effect of gut microbiota on drug metabolism
- (2013) Mi Jeong Kang et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats
- (2013) Na Gao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Concentration-Dependent Inhibitory Effect of Baicalin on the Plasma Protein Binding and Metabolism of Chlorzoxazone, a CYP2E1 Probe Substrate, in Rats In Vitro and In Vivo
- (2013) Na Gao et al. PLoS One
- Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
- (2013) Caitriona M. Guinane et al. Therapeutic Advances in Gastroenterology
- Role of metabolism by human intestinal microflora in geniposide-induced toxicity in HepG2 cells
- (2012) Mi Jeong Kang et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of Metabolism by Intestinal Bacteria in Arbutin-Induced Suppression of Lymphoproliferative Response in vitro
- (2012) Mi-Jeong Kang et al. Biomolecules & Therapeutics
- The Role of Intestinal Microflora in Anti-Inflammatory Effect of Baicalin in Mice
- (2012) Myung-Ah Jung et al. Biomolecules & Therapeutics
- Comparative pharmacokinetics of baicalin in normal and the type 2 diabetic rats after oral administration of the Radix scutellariae extract
- (2012) Yuan-Xiong Deng et al. FITOTERAPIA
- Protective role of intestinal bacterial metabolism against baicalin-induced toxicity in HepG2 cell cultures
- (2012) Tilak Khanal et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Role of intestinal microflora in xenobiotic-induced toxicity
- (2012) Hye Gwang Jeong et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: Possible role of cytochrome p450 3A4 and P-glycoprotein inhibition by baicalein
- (2011) Cheng Li et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of metabolism by intestinal bacteria in arbutin-induced toxicity in vitro
- (2011) Mi Jeong Kang et al. ARCHIVES OF PHARMACAL RESEARCH
- Detection of Baicalin Metabolites Baicalein and Oroxylin-A in Mouse Pancreas and Pancreatic Xenografts
- (2011) Qing-Yi Lu et al. PANCREAS
- Comparative Analysis of Korean Human Gut Microbiota by Barcoded Pyrosequencing
- (2011) Young-Do Nam et al. PLoS One
- Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice
- (2010) Hien-trung Trinh et al. ACTA PHARMACOLOGICA SINICA
- Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free Rats
- (2010) Ming Ji Jin et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- Gut Microbiota in Health and Disease
- (2010) Inna Sekirov et al. PHYSIOLOGICAL REVIEWS
- The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease
- (2009) Patrice Cani et al. CURRENT PHARMACEUTICAL DESIGN
- New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
- (2008) Min Li-Weber CANCER TREATMENT REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started